-
Mashup Score: 1
Cancer Discovery | 14 | 11 | November 2024
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8
Summary:. Current strategies for early cancer detection and diagnosis need updating to achieve greater precision, necessitating the creation of a comprehensive evolutionary map of tumorigenesis. This requires establishing high-quality prospective cohorts, systematically collecting samples for integrated spatiotemporal multiomics analyses, and efficiently translating laboratory findings into clinical applications.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 11Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection - 13 day(s) ago
A high-sensitivity, low-cost cell-free DNA fragmentome test is validated in the population eligible for lung cancer screening, with the potential to prevent thousands of deaths if used to close screening shortfalls.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Alerts | American Association for Cancer Research - 14 day(s) ago
Alerts | American Association for Cancer Research .main-content h1 { font-weight: 300; color: #44b13e; margin-bottom: 0; } .main-content h3 { margin-bottom: 16px; } .main-content h3 a{ color: rgb(76, 167, 68); } .main-content h3 a{ margin-bottom: 12px; } .main-content div img{ float: left; margin: 0 16px 12px 0; } .main-content div ul { list-style-image: url(‘/ImageLibrary/umbrella/icons/Pubs_bullet.png’); list-style-position: inside; }…
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 9
Early Career Award | Cancer Discovery | American Association for Cancer Research .aacrcontent .banner{ width: 100% margin: -20px; } .aacrcontent .banner-sm{ display: none; } .right{float: right; margin: 0 16px 16px 16px; padding: 16px; width: 220px; background-color: #f0f0f0; border: solid 1px #ddd;} .aacrcontent2 { box-shadow: 3px 3px 6px #ccc, -3px -3px 6px #ccc; font-size: 16px; max-width: 400px; padding: 16px;} .copy h3{margin-top: 20px;} /*…
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7
The phase 1 trial of mRNA-4157, an individualized neoantigen therapy, demonstrated strong T-cell responses and manageable safety, showing promise as a novel cancer immunotherapy in patients with resected NSCLC or melanoma.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Cancer Prevalence across Vertebrates - 18 day(s) ago
Abstract. Cancer is pervasive across multicellular species, but what explains the differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades of tetrapods (amphibians, sauropsids, and mammals), we found that neoplasia and malignancy prevalence increases with adult mass (contrary to Peto’s paradox) and somatic mutation rate but decreases with gestation time. The relationship between adult mass and malignancy prevalence was only apparent when we controlled for gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%), the black-footed penguin (<0.4%), ferrets (63%), and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and preven
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5
The receptor tyrosine kinase ROR2 defines the cellular identity of pancreatic precancerous lesions and confers aggressiveness and therapeutic resistance in cancer.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 9Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer - 19 day(s) ago
The RAS(ON) multi-selective inhibitor RMC-7977, with or without covalent RAS(ON)G12C targeting, induces sustained regressions in KRAS-mutant NSCLC models, but long-term antitumor activity is curtailed by a mucinous tolerogenic transcriptional state.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Medicare Changes for 2025 Set - 20 day(s) ago
Under its 2025 Physician Fee Schedule (PFS), the Centers for Medicare & Medicaid Services (CMS) announced that physicians will be paid, on average, nearly 3% less next year compared with 2024 reimbursement rates. The PFS is the primary method the CMS uses to pay healthcare providers; it relies on a conversion factor to determine how much physicians will be paid based on their costs and time. In addition, Medicare will expand coverage of colorectal cancer screening to include computer tomography colonography and blood-based biomarker screening, which will “remove barriers for much needed cancer prevention and early detection within rural communities and communities of color that are especially impacted” by the incidence of colorectal cancer, according to the CMS.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
Read the special collection of commentaries by cancer researchers in China, in the November issue of Cancer Discovery. https://t.co/pF21blla3Q https://t.co/qETv2trv48